Ensuring Optimal Management of Antibiotic-Resistant Hospital- and Ventilator-Acquired Pneumonia

Target Audience
Infectious disease physicians, infectious disease pharmacists, critical care specialists, pharmacy/formulary directors, and other providers who treat and/or monitor patients with hospital- or ventilator-acquired pneumonias (eg, clinical pharmacists, clinical microbiologists, hospitalists)

Learning Objectives
After completing this activity, participants should be better able to:

Review the diagnostic approach and pathophysiology of hospital- and ventilator-acquired bacterial pneumonia.
Describe the health and economic burden of hospital- and ventilator-acquired pneumonia.
Explain the major mechanisms of resistance seen in nosocomial pneumonias.
Develop an optimal treatment plan incorporating novel therapies for patients with hospital- or ventilator-acquired bacterial pneumonia including those with antibiotic resistance.